Solid Biosciences Inc. SLDB Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$191.78M-10.0% | -$174.33M-4.3% | -$167.14M-8.5% | -$154.08M-10.3% | -$139.68M-12.0% | ||
| $1.62M-0.7% | $1.64M-1.3% | $1.66M-1.7% | $1.69M-33.5% | $2.54M+3.3% | ||
| $18.73M+10.7% | $16.91M+18.8% | $14.24M+7.0% | $13.3M+8.6% | $12.25M+16.4% | ||
| -$171.67M-9.8% | -$156.29M-18.1% | -$132.38M-8.0% | -$122.62M-14.9% | -$106.67M-6.7% | ||
| $1.19M+3.4% | $1.15M+45.6% | $792K+9.7% | $722K+14.4% | $631K-3.5% | ||
| —— | —— | —— | —— | —— | ||
| $588K-18.7% | $723K+11.6% | $648K+23.4% | $525K-13.7% | $608K+28.5% | ||
| $245.35M+25.1% | $196.05M-0.9% | $197.84M-1.0% | $199.92M-2.4% | $204.92M+67.4% | ||
| $85.84M+523% | -$20.3M-568% | -$3.04M-107% | $43.09M— | —— | ||
| -$172.86M-9.8% | -$157.44M-18.2% | -$133.17M-8.0% | -$123.34M-14.9% | -$107.3M-6.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Solid Biosciences Inc. generate?
- Solid Biosciences Inc. (SLDB) generated -$171.7M in operating cash flow over the trailing twelve months.
- What is Solid Biosciences Inc.'s free cash flow?
- After $1.2M of capital expenditures, Solid Biosciences Inc.'s free cash flow was -$172.9M over the trailing twelve months, down 61.1% year over year.
- Where does Solid Biosciences Inc.'s cash flow data come from?
- Every line is extracted from Solid Biosciences Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
